Cell Therapy News Volume 22.09 | Mar 15 2021

    0
    368






    CTN 22.09 | Mar 15 2021


    Cell Therapy News by STEMCELL Technologies
    Vol. 22.09 – 15 March, 2021
    TOP STORY

    Regnase-1 Suppresses TCF-1+ Precursor Exhausted T Cell Formation to Limit CAR T Cell Responses against ALL

    The authors demonstrated using an immune-competent mouse model of B cell acute lymphoblastic leukemia that Regnase-1 deficiency promoted TCF-1 expression to enhance CAR-T cell expansion and memory-like cell formation.
    [Blood]

    Abstract

    Dr. Jackie Damen discusses why the CFU assay should be a vital part of your cell therapy workflow in this on-demand webinar.
    PUBLICATIONSRanked by the impact factor of the journal

    Hematopoietic Stem Cell Gene Therapy Targeting TGFβ Enhances the Efficacy of Irradiation Therapy in a Preclinical Glioblastoma Model

    Transplantation of hematopoietic stem cells transduced with lentiviral vector expressing green florescent protein into lethally irradiated recipient mice was followed by intracranial implantation of glioblastoma cells.
    [Journal For Immunotherapy of Cancer]

    Full Article

    Longitudinal Neuroimaging Evaluation of the Corticospinal Tract in Patients with Stroke Treated with Autologous Bone Marrow Cells

    Scientists imaged 37 patients with stroke, 17 patients treated with mononuclear cells and 20 patients who received standard of care.
    [STEM CELLS Translational Medicine]

    Full Article

    Mesenchymal Stem Cells Overexpressing BMP-9 by CRISPR-Cas9 Present High In Vitro Osteogenic Potential and Enhance In Vivo Bone Formation

    Researchers genetically edited mesenchymal stem cells (MSCs) to overexpress bone morphogenetic protein 9 (BMP-9) using CRISPR-Cas9 to generate iMSCs-VPRBMP-9+, followed by in vitro evaluation of osteogenic potential and in vivo enhancement of bone formation in rat calvaria defects.
    [Gene Therapy]

    Abstract

    Functional Expression of Complement Factor I Following AAV-Mediated Gene Delivery in the Retina of Mice and Human Cells

    Scientists demonstrated the generation of AAV constructs carrying the human Complement Factor I (CFI) sequence and expression of CFI in cell lines and in the retina of C57BL/6 J mice.
    [Gene Therapy]

    Full Article

    Generation of Pulmonary Endothelial Progenitor Cells for Cell-Based Therapy Using Interspecies Mouse-Rat Chimeras

    Single cell RNA sequencing of neonatal human and mouse lung was used to identify the heterogeneity of pulmonary endothelial progenitor cells (EPCs). CRISPR/Cas9 gene editing was used to genetically label and purify mouse pulmonary EPCs.
    [American Journal of Respiratory and Critical Care Medicine]

    Abstract

    Gap Junction‐Mediated Cell‐Cell Interaction between Transplanted Mesenchymal Stem Cells and Vascular Endothelium in Stroke

    Researchers investigated such cell‐cell interaction between mesenchymal stem cells (MSCs) and cerebral endothelial cells. In contrast to bone marrow mononuclear cells, for MSCs they observed suppression of vascular endothelial growth factor uptake into endothelial cells and transfer of glucose from endothelial cells to MSC in vitro.
    [Stem Cells]

    Abstract

    3D Bioprinting of Prevascularised Implants for the Repair of Critically-Sized Bone Defects

    Investigators developed a bioprinting strategy to engineer prevascularised tissues in vitro and to investigate the capacity of such constructs to enhance the vascularisation and regeneration of large bone defects in vivo.
    [Acta Biomaterialia]

    Full Article

    Conditionally Immortalized Leukemia Initiating Cells Co-Expressing Hoxa9/Meis1 Demonstrate Microenvironmental Adaptation Properties Ex Vivo while Maintaining Myelomonocytic Memory

    The authors established conditionally immortalized myeloid progenitor cell lines co-expressing constitutive Hoxa9.EGFP and inducible Meis1.dTomato to study growth behavior, immunophenotype and morphology under different cytokine/microenvironmental conditions ex vivo upon doxycycline induction or removal.
    [Scientific Reports]

    Full Article

    Targeted Therapy of Human Leukemia Xenografts in Immunodeficient Zebrafish

    Researchers describe a novel strategy for establishing a zebrafish model for drug testing in leukemia xenografts. They used chronic myelogenous leukemia and acute myeloid leukemia for xenotransplantation into severe combined immunodeficiency zebrafish to evaluate drug screening protocols.
    [Scientific Reports]

    Full Article

    The StemSpan™ T Cell Generation Kit is designed to promote differentiation of HSPCs into T cells in stroma- and serum-free culture conditions.
    REVIEWS

    The Evolving Concept of Indications for Allogeneic Hematopoietic Cell Transplantation during First Complete Remission of Acute Myeloid Leukemia

    Improvements in clinical applications of genetic and measurable residual disease information as well as in transplantation technology are expected to further refine indications for allogeneic hematopoietic cell transplantation during first complete remission.
    [Bone Marrow Transplantation]

    Abstract

    Recent Advances in Immune Therapies for Gastric Cancer

    The authors summarize the current state of knowledge on immune mechanisms of gastric cancer and the status of emerging immunotherapies to treat this aggressive cancer, as well as outline current challenges and directions for future research.
    [Cancer Gene Therapy]

    Abstract

    Genome Editing Using CRISPR/Cas9 to Treat Hereditary Hematological Disorders

    Scientists review and summarize the latest studies about CRISPR/Cas9-mediated genome editing in patient-derived HSPCs and iPSCs to treat hereditary hematological disorders.
    [Gene Therapy]

    Abstract

    INDUSTRY AND POLICY NEWS

    Hepatx, Namocell, and Takara Bio USA Complete Second Phase of Collaboration on Single Cell Analysis for Cell Therapy to Treat Late-Stage Liver Diseases

    HepaTx Corporation, Namocell Inc., and Takara Bio USA, Inc. announced successful completion of the second phase of their collaboration on single cell analysis of hepatocyte-like cells differentiated from adipose tissue-derived stromal cells using Namocell’s Single Cell Dispensers and Takara Bio’s SMART-seq® kits to characterize HepaTx’s novel cell therapies for liver disease.
    [HepaTx Corporation (PR Newswire Inc.)]

    Press Release

    New Multi-Faculty Center for Cell Therapy Translation Gives UCalgary Skin in the Game for Regenerative Medicine Research

    The Schulich School of Engineering, under Dr. Michael Kallos, a professor in the Department of Chemical and Petroleum Engineering, and director of the Biomedical Engineering Calgary Initiative, has been developing technologies to safely and reproducibly grow stem cells- whether they be skin cells, neural cells, or cells in any other part of the body.
    [University of Calgary]

    Press Release

    FEATURED EVENT

    Genomics of Rare Disease

    March 22 – 24, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Lab Scientist – Tissue and Cellular Therapy

    The University of Iowa – Iowa City, Iowa, United States

    Stem Cell Core Director – Stem Cell Research

    Gladstone Institute – San Francisco, California, United States

    Research Assistant – Cellular Manufacturing

    National University of Ireland Galway – Galway, Ireland

    Research Fellow – RNA Biology

    Dana-Farber Cancer Institute – Boston, Massachusetts, United States

    Postdoctoral Fellow – Genomics of Endocrine Traits

    Children’s Hospital of Philadelphia – Philadelphia, Pennsylvania, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Cell Therapy News Twitter